Some researchers have proposed that, as in liver cancer, new risk signatures constructed from 5 m6A-related genes (METTL3, METTL14, KIAA1429, ALKBH5 and YTHDF1) can be used as independent prognostic factors for PAAD [134]. The gene discussed is METTL3; the disease is liver cancer.